| Trial ID: | L0711 |
| Source ID: | NCT04890704
|
| Associated Drug: |
Curcuminoid
|
| Title: |
Curcuminoids and Contrast-induced Acute Kidney Injury
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Kidney Injury|Contrast Media Toxicity|Curcuminoid|Chronic Kidney Diseases
|
| Interventions: |
DRUG: Curcuminoid|DRUG: Placebo
|
| Outcome Measures: |
Primary: The incidence of AKI, the incidence of CI-AKI development between the addition of curcuminoids to standard protocol and standard protocol alone in patients who underwent CAG, 48 hours | Secondary: AKI of any cause within seven days after CAG, The incidence overallof AKI form any causes, 7 days|Change in eGFR, The final eGFR compared to baseline eGFR before CAG, 0,7 days|Change in IL-6 and hs-CRP, The final levels of inflammatory markers at the completion of study compare to baseline, 0.7 days|Adverse events, The adverse events of curcuminoids, 7 days
|
| Sponsor/Collaborators: |
Sponsor: Bangkok Metropolitan Administration Medical College and Vajira Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
96
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2018-10-01
|
| Completion Date: |
2019-05-31
|
| Results First Posted: |
|
| Last Update Posted: |
2021-05-18
|
| Locations: |
Navamindradhiraj University, Bangkok, 10300, Thailand
|
| URL: |
https://clinicaltrials.gov/show/NCT04890704
|
